Pharmacy technician shortages remain one of the most persistent operational challenges facing hospitals, but leaders say the problem extends beyond wage competition. While higher pay from large retailers continues to draw talent away from health systems, pharmacy executives point to…
Pharmacy
The Utah Medical Licensing Board has called for the suspension of an AI pilot program that automates prescription renewals. The program, launched through an agreement between the state of Utah and Doctronic, a reportedly free and anonymous online AI platform…
CenterWell, Humana’s pharmacy branch, is collaborating with Mark Cuban’s Cost Plus Drug Co. for an employer-based program, according to an April 27 news release. CenterWell will use Cost Plus Drugs’ SwiftyRx, a digital pharmacy software-as-a-service solution, for medication order intake.…
Johnson & Johnson will begin marketing four prescription drugs on the Trump administration’s TrumpRx website, according to an April 24 report from CBS News. The drugs include metformin, metformin extended release, Invokana and Xarelto. Pricing on the platform shows Invokana…
Bristol Myers Squibb and Pfizer will offer Eliquis through Mark Cuban Cost Plus Drug Company, expanding access for cash-paying patients. Beginning April 27, patients with a prescription can purchase a 30-day supply of the drug on CostPlusDrugs.com for $345, according…
Advertisement
Regeneron has become the final major drugmaker to reach a pricing agreement with the Trump administration, joining a wave of industry deals aimed at lowering U.S. drug costs. The agreement includes several pricing and access commitments. Regeneron said it will…
The FDA has approved Otarmeni, the first gene therapy for genetic hearing loss, through its National Priority Voucher program. The therapy is indicated for pediatric and adult patients with severe-to-profound hearing loss tied to OTOF gene mutations, according to an…
Two potential pancreatic cancer treatments are gaining recognition within the oncology community, according to reports from The New York Times and The Washington Post published April 21 and April 22, respectively. One treatment is a pill called darxonrasib. Developed by…
Drugmakers and industry groups are accelerating investments in AI, manufacturing and dealmaking while navigating regulatory and policy shifts. Recent moves reflect a broader push to speed drug development, expand production capacity and reposition portfolios amid competitive and political pressure. Here…
An experimental gene therapy restored at least some level hearing in most patients with a rare form of inherited deafness, a study found. The study, published April 22 in Nature, evaluated 42 children and adults with autosomal recessive deafness 9,…